Literature DB >> 1851348

Impaired interferon-alpha production in whole-blood cultures from bladder cancer patients.

J Y Kuo1, Y Nishio, H Kanamaru, Y Okada, M Kita, J Imanishi, T Kishida, O Yoshida.   

Abstract

Interferon-alpha (IFN-alpha) production was investigated in whole-blood cultures of 66 bladder cancer patients and 65 control subjects. IFN synthesis was induced with Sendai virus, and IFN activity was assayed in FL cells challenged with vesicular stomatitis virus (VSV). The mean levels of the IFN-alpha produced were 5,724 +/- 2,288 IU/ml in the control subjects and 4,800 +/- 2,353 IU/ml in the bladder cancer patients. IFN-alpha production was significantly suppressed in the bladder cancer patients compared with that in the control subjects (P less than 0.05). The impairment in IFN-alpha production correlated with the tumor grade, and it was shown that the tendency toward decreased IFN-alpha production was closely associated with the advancement of the tumor stage. Our results suggested that the decreased IFN-alpha production may contribute to the disordered immunoregulation in bladder cancer patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851348     DOI: 10.1007/bf00294022

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  20 in total

1.  Virus interference. I. The interferon.

Authors:  A ISAACS; J LINDENMANN
Journal:  Proc R Soc Lond B Biol Sci       Date:  1957-09-12

2.  Cellular and humoral immune responses to human urinary bladder carcinomas.

Authors:  J Bubeník; P Perlmann; K Helmstein; G Moberger
Journal:  Int J Cancer       Date:  1970-05-15       Impact factor: 7.396

3.  Interferon induction and augmentation of natural-killer activity by Staphylococcus protein A.

Authors:  T L Ratliff; R E McCool; W J Catalona
Journal:  Cell Immunol       Date:  1981-01-01       Impact factor: 4.868

4.  Monocyte is the main producer of human leukocyte alpha interferons following Sendai virus induction.

Authors:  E Saksela; I Virtanen; T Hovi; D S Secher; K Cantell
Journal:  Prog Med Virol       Date:  1984

5.  Preparation and assay of Sendai virus.

Authors:  K Cantell; S Hirvonen
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Immunologic evaluation of human bladder cancer: in vitro studies.

Authors:  M M Elhilali; S K Nayak
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

7.  Target cells for interferon production in human leukocytes stimulated by sendai virus.

Authors:  T Yamaguchi; K Handa; Y Shimizu; T Abo; K Kumagai
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

8.  Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  P A Neighbour; A I Grayzel
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

9.  A unifying model of the immunoregulatory role of the interferon system: can interferon produce disease in humans?

Authors:  S Skurkovich; B Skurkovich; J A Bellanti
Journal:  Clin Immunol Immunopathol       Date:  1987-06

10.  Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors.

Authors:  I Gresser; F Belardelli; C Maury; M T Maunoury; M G Tovey
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  1 in total

1.  Impaired cytokine production in whole blood cell cultures of patients with urological carcinomas.

Authors:  U Elsässer-Beile; S von Kleist; R Fischer; M Martin; U Wetterauer; H Gallati; J S Mönting
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.